US5220012A
(en)
*
|
1984-09-26 |
1993-06-15 |
Compagnie Oris Industrie Sa |
Macropolycyclic rare earth complexes and application as fluorescent tracers
|
SE454781B
(sv)
*
|
1986-10-17 |
1988-05-30 |
Wallac Oy |
Hybridiseringsforfarande for detektion av polynukleotidsekvens
|
US5162508A
(en)
*
|
1987-12-18 |
1992-11-10 |
Compagnie Oris Industrie |
Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers
|
FR2624862B1
(fr)
*
|
1987-12-18 |
1990-06-08 |
Oris Ind |
Cryptates de terres rares, procedes d'obtention, intermediaires de synthese et application a titre de marqueurs fluorescents
|
US5134232A
(en)
*
|
1988-11-14 |
1992-07-28 |
The Regents Of The University Of California |
Fluorescent indicator dyes for alkali metal cations
|
US5094759A
(en)
*
|
1989-03-17 |
1992-03-10 |
The University Of Southern Mississippi |
Method of water treatment using 2,6-substituted aminopyridines and polymer derived therefrom
|
US5216134A
(en)
*
|
1989-10-23 |
1993-06-01 |
Wallac Oy |
Spectrofluorometric method and compounds that are of value for the method
|
FR2664699B1
(fr)
*
|
1990-07-13 |
1995-08-18 |
Cis Bio Int |
Procede d'amplification du signal d'emission d'un compose luminescent.
|
WO1992005804A1
(en)
*
|
1990-09-27 |
1992-04-16 |
Brunswick Corporation |
Chelating agents
|
EP0493745A1
(de)
*
|
1990-12-21 |
1992-07-08 |
Dojindo Laboratories |
Fluoreszierende Verbindung, Komplex, Reagenz und spezifische Bindungtest
|
CA2072934C
(en)
*
|
1991-07-19 |
2007-08-28 |
Karl William Aston |
Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
|
FR2680787B1
(fr)
*
|
1991-08-30 |
1994-11-04 |
Cis Bio Int |
Complexes macrocycliques de terres rares et leur utilisation pour reduire les interferences dans un dosage par fluorescence.
|
WO1993011433A1
(en)
*
|
1991-12-05 |
1993-06-10 |
Wallac Oy |
Luminescent lanthanide chelates
|
US5417959A
(en)
*
|
1993-10-04 |
1995-05-23 |
Mallinckrodt Medical, Inc. |
Functionalized aza-crytand ligands for diagnostic imaging applications
|
AU1694895A
(en)
*
|
1994-01-28 |
1995-08-15 |
Mallinckrodt Medical, Inc. |
Functionalized aza-bimacrocyclic ligands for imaging applications
|
US6017496A
(en)
|
1995-06-07 |
2000-01-25 |
Irori |
Matrices with memories and uses thereof
|
US6329139B1
(en)
|
1995-04-25 |
2001-12-11 |
Discovery Partners International |
Automated sorting system for matrices with memory
|
US5792330A
(en)
*
|
1995-05-31 |
1998-08-11 |
Board Of Regents, The University Of Texas System |
Lanthanide metal cations for concurrent detection and separation in capillary electrophoresis
|
FR2768817B1
(fr)
*
|
1997-09-19 |
1999-12-10 |
Cis Bio Int |
Methode homogene pour la detection et/ou la determination de l'activite phosphorylante d'un materiel biologique
|
FR2769315B1
(fr)
*
|
1997-10-03 |
2001-06-08 |
Cis Bio Int |
Conjugues fluorescents de nucleosides ou de nucleotides, leur procede de preparation et leur utilisation
|
EP1064360B1
(de)
|
1998-03-27 |
2008-03-05 |
Prolume, Ltd. |
Luciferase, gfp fluoreszenzproteine, kodierende nukleinsaüre und ihre verwendung in der diagnose
|
EP1925320A3
(de)
|
1998-03-27 |
2008-09-03 |
Prolume, Ltd. |
Luciferasen, fluoreszierende Proteine, Nukleinsäuren zur Kodierung der Luciferasen und der fluoreszierenden Proteine sowie deren Verwendung zur Diagnose, zum Screening mit hohem Durchsatz und zur Behandlung neuartiger Probleme
|
US7109315B2
(en)
*
|
2000-03-15 |
2006-09-19 |
Bruce J. Bryan |
Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
|
FR2809817B1
(fr)
|
2000-06-02 |
2003-08-15 |
Cis Bio Int |
Procede de detection de presence d'un liquide dans un melange
|
FR2810406B1
(fr)
*
|
2000-06-15 |
2002-09-20 |
Cis Bio Int |
Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
|
AU2003291677A1
(en)
*
|
2002-10-30 |
2004-05-25 |
Pointilliste, Inc. |
Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides
|
AU2003290561A1
(en)
*
|
2003-02-10 |
2004-09-06 |
Dana Ault-Riche |
Self-assembling arrays and uses thereof
|
US7018851B2
(en)
*
|
2003-02-13 |
2006-03-28 |
Innotrac Diagnostics Oy |
Biospecific binding reactants labeled with new luminescent lanthanide chelates and their use
|
CA2445420A1
(en)
*
|
2003-07-29 |
2005-01-29 |
Invitrogen Corporation |
Kinase and phosphatase assays
|
US7727752B2
(en)
*
|
2003-07-29 |
2010-06-01 |
Life Technologies Corporation |
Kinase and phosphatase assays
|
US7619059B2
(en)
*
|
2003-07-29 |
2009-11-17 |
Life Technologies Corporation |
Bimolecular optical probes
|
US20050064485A1
(en)
*
|
2003-09-12 |
2005-03-24 |
Kurt Vogel |
Multiplex binding and activity assays
|
US20050095648A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Mario Geysen |
Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
|
WO2005046735A1
(en)
*
|
2003-11-07 |
2005-05-26 |
Newport Instruments |
A reagent system and method for modifying the luminescence of lanthanide(iii) macrocyclic complexes
|
US20060018911A1
(en)
*
|
2004-01-12 |
2006-01-26 |
Dana Ault-Riche |
Design of therapeutics and therapeutics
|
US20060024725A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Robert Hussa |
Oncofetal fibronectin as a marker for pregnancy-related indications
|
FR2878850B1
(fr)
*
|
2004-12-02 |
2008-10-31 |
Cis Bio Internat Sa |
Derives de l'inositol-1-phosphate
|
DE102005020384A1
(de)
*
|
2005-05-02 |
2006-11-09 |
Therainvention Gmbh |
Spektroskopisches Verfahren zum Nachweis von Analyten
|
JP4559922B2
(ja)
*
|
2005-06-21 |
2010-10-13 |
株式会社東芝 |
蛍光性錯体及びそれを用いた照明装置
|
FR2890174B1
(fr)
*
|
2005-08-30 |
2009-04-24 |
Cis Bio Internat Sa |
Procede pour la mise en evidence d'un processus biologique par mesure d'un fret
|
FR2890446B1
(fr)
|
2005-09-05 |
2008-04-18 |
Cis Bio Internat Sa |
Methode de detection d'interaction intracellulaire entre bio-molecules
|
EP2221385A3
(de)
|
2005-10-28 |
2010-12-01 |
Life Technologies Corporation |
Deubiquinations-Assays
|
US7482444B2
(en)
*
|
2006-03-13 |
2009-01-27 |
Wallac Oy |
Terminating substrates for DNA polymerases
|
DE102006021406B4
(de)
|
2006-05-08 |
2008-08-07 |
B.R.A.H.M.S Aktiengesellschaft |
In vitro Verfahren zur Früherkennung von arznei- und suchtmittelinduzierten Leberschäden und zur Erkennung der bereits erreichten Stufe der Leberschädigung
|
JP5237949B2
(ja)
|
2006-08-18 |
2013-07-17 |
アバクス ディアグノスティカ オイ |
発光性ランタノイド標識試薬及びその用途
|
US20090306368A1
(en)
*
|
2006-11-27 |
2009-12-10 |
Sumitomo Chemical Company, Limited |
Polynuclear complex
|
DE102007009751A1
(de)
|
2007-02-28 |
2008-09-04 |
B.R.A.H.M.S Aktiengesellschaft |
Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
|
DE102007022367A1
(de)
|
2007-05-07 |
2008-11-20 |
B.R.A.H.M.S Ag |
Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
|
WO2010006605A2
(en)
*
|
2008-07-16 |
2010-01-21 |
Radiometer Medical Aps |
Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
|
FR2934684B1
(fr)
|
2008-07-31 |
2012-11-16 |
Cis Bio Int |
Methode de detection de l'internalisation de proteines membranaires.
|
FR2936245B1
(fr)
|
2008-09-23 |
2012-07-06 |
Cis Bio Int |
Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants.
|
FR2940286B1
(fr)
|
2008-12-19 |
2011-04-08 |
Cis Bio Int |
Nouveaux cryptates de terres rares comportant un motif tetraazatriphenylene
|
FI20090100A0
(fi)
|
2009-03-16 |
2009-03-16 |
Wallac Oy |
Biotinidaasimääritys
|
JP5732452B2
(ja)
|
2009-04-30 |
2015-06-10 |
セイエス ビオ アンテルナショナル |
Vftドメイン膜タンパク質のダイマーを調節する化合物の検出方法
|
FR2949156B1
(fr)
|
2009-08-13 |
2016-04-15 |
Cis-Bio Int |
Methode de determination de la liaison d'un compose donne a un recepteur membranaire
|
FR2977674B1
(fr)
|
2011-07-06 |
2015-08-14 |
Cisbio Bioassays |
Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
|
FR2978149B1
(fr)
|
2011-07-18 |
2014-01-10 |
Cisbio Bioassays |
Nouveaux agents complexants et complexes de lanthanide correspondant, et leur utilisation comme marqueurs luminescents
|
FR2980271B1
(fr)
|
2011-09-16 |
2013-10-11 |
Cisbio Bioassays |
Procede de determination de la glycosylation d'un anticorps
|
WO2013042120A2
(en)
|
2011-09-19 |
2013-03-28 |
Proteologics Ltd |
Synthetic ubiquitins and use thereof in drug screening assays
|
WO2013124544A1
(fr)
|
2012-02-22 |
2013-08-29 |
Cisbio Bioassays |
Procede de normalisation de la luminescence emise par un milieu de mesure.
|
FR2988174B1
(fr)
|
2012-03-19 |
2014-04-25 |
Cisbio Bioassays |
Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
|
WO2014136115A1
(en)
|
2013-03-07 |
2014-09-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Non-selfabsorbing luminescent solar concentrator
|
FR3004189B1
(fr)
|
2013-04-04 |
2015-09-04 |
Ecole Norm Superieure Lyon |
Complexes de lanthanide comprenant au moins deux groupes betaines, utiles comme marqueurs luminescents
|
FR3032797B1
(fr)
|
2015-02-13 |
2017-03-03 |
Cisbio Bioassays |
Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
|
WO2017089474A1
(en)
|
2015-11-27 |
2017-06-01 |
Brahms Gmbh |
MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT
|
FR3045053B1
(fr)
|
2015-12-09 |
2018-01-05 |
Cisbio Bioassays |
Agents complexants hydrosolubles a base de triazapyridinophane et complexes de lanthanide fluorescents correspondants
|
CA3010895A1
(en)
|
2016-01-21 |
2017-07-27 |
SeLux Diagnostics, Inc. |
Methods for rapid antimicrobial susceptibility testing
|
US9834808B2
(en)
|
2016-01-21 |
2017-12-05 |
SeLux Diagnostics, Inc. |
Methods for rapid antibiotic susceptibility testing
|
RU2765212C2
(ru)
|
2016-08-09 |
2022-01-26 |
Б.Р.А.Х.М.С. Гмбх |
Гистоны и/или proadm в качестве маркеров, свидетельствующих о неблагоприятном событии
|
CN109564226A
(zh)
|
2016-08-09 |
2019-04-02 |
B.R.A.H.M.S 有限公司 |
作为指示器官功能障碍的标志物的组蛋白和/或proADM
|
MA47019A
(fr)
|
2016-12-16 |
2021-04-21 |
H Lundbeck As |
Agents, utilisations et procédés
|
JP7146765B2
(ja)
|
2016-12-23 |
2022-10-04 |
セルックス・ダイアグノスティクス・インコーポレイテッド |
改善された迅速な抗菌薬感受性試験のための方法
|
ES2944613T3
(es)
|
2017-02-02 |
2023-06-22 |
Brahms Gmbh |
proADM y/o histonas como marcadores indicadores de un acontecimiento adverso
|
EP3631460B1
(de)
|
2017-05-31 |
2023-11-15 |
B.R.A.H.M.S GmbH |
Mmp-8 als marker für neurodegenerative erkrankungen
|
FR3067349B1
(fr)
|
2017-06-12 |
2020-12-04 |
Cisbio Bioassays |
Nouveaux agents mono et di-antennes complexants hydrosolubles et complexes de lanthanide correspondants
|
FR3067712B1
(fr)
|
2017-06-14 |
2019-08-02 |
Cisbio Bioassays |
Nouveaux agents complexants de type trimethoxyphenyl pyridine hydrosolubles et complexes de lanthanide correspondants
|
FR3069644A1
(fr)
|
2017-07-28 |
2019-02-01 |
Cisbio Bioassays |
Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
|
WO2019053116A1
(en)
|
2017-09-13 |
2019-03-21 |
B.R.A.H.M.S Gmbh |
FLUID THERAPY GUIDING METHOD BASED ON PROADRENOMEDULLINE
|
EP3502691A1
(de)
|
2017-12-20 |
2019-06-26 |
B.R.A.H.M.S GmbH |
Proadrenomedullin als indikator für nierenersatztherapie bei kritisch kranken patienten
|
ES2913298T3
(es)
|
2017-09-13 |
2022-06-01 |
Brahms Gmbh |
PCT y proADM como marcadores para el seguimiento del tratamiento antibiótico
|
CN111065922A
(zh)
|
2017-09-13 |
2020-04-24 |
B.R.A.H.M.S有限公司 |
肾上腺髓质素原作为危重病患者的肾脏替代治疗的指标
|
JP7346389B2
(ja)
|
2017-09-13 |
2023-09-19 |
ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
異常な血小板レベルのマーカーとしてのプロアドレノメジュリン
|
US20210109118A1
(en)
|
2017-12-20 |
2021-04-15 |
B.R.A.H.M.S Gmbh |
Antibiotic therapy guidance based on pro-adm
|
WO2019122088A1
(en)
|
2017-12-20 |
2019-06-27 |
B.R.A.H.M.S Gmbh |
Antibiotic therapy guidance based on procalcitonin in patients with comorbidities
|
MA51295A
(fr)
|
2017-12-21 |
2021-05-05 |
H Lundbeck As |
Dosage, procédé et traitement d'alpha-synucléinopathies
|
EP3578989A1
(de)
|
2018-06-06 |
2019-12-11 |
B.R.A.H.M.S GmbH |
Pro-adm zur prognose von traumabedingten komplikationen bei polytraumapatienten
|
FR3084365B1
(fr)
|
2018-07-27 |
2020-10-23 |
Cisbio Bioassays |
Anticorps a domaine unique qui se lient a la proteine g alpha
|
EP3608673A1
(de)
|
2018-08-08 |
2020-02-12 |
B.R.A.H.M.S GmbH |
Pro-adm zur prognose des risikos einer erkrankung, die einen krankenhausaufenthalt bei patienten mit symptomen einer infektionskrankheit erfordert
|
EP3918343A1
(de)
|
2019-01-28 |
2021-12-08 |
B.R.A.H.M.S GmbH |
Verfahren zur vorhersage der behandlungsreaktion bei patienten mit nächtlicher enurese
|
FR3092172B1
(fr)
|
2019-01-30 |
2021-02-12 |
Cisbio Bioassays |
Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
|
WO2020169819A1
(en)
|
2019-02-21 |
2020-08-27 |
B.R.A.H.M.S Gmbh |
Diagnosis or prognosis of postsurgical adverse events
|
JP2022526507A
(ja)
|
2019-03-29 |
2022-05-25 |
ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
バイオマーカーに基づく遠隔患者管理の処方
|
EP3715851A1
(de)
|
2019-03-29 |
2020-09-30 |
B.R.A.H.M.S GmbH |
Verschreibung von fernpatientenmanagement auf der basis von biomarkern
|
US11845976B2
(en)
|
2019-08-27 |
2023-12-19 |
SeLux Diagnostics, Inc. |
Systems and methods for performing antimicrobial susceptibility testing
|
AU2021251382A1
(en)
|
2020-04-06 |
2022-10-20 |
B.R.A.H.M.S Gmbh |
Pro-adrenomedullin for prognosing disease progression in severe acute respiratory syndrome (SARS)
|
US20230176074A1
(en)
|
2020-04-09 |
2023-06-08 |
B.R.A.H.M.S Gmbh |
Biomarkers for the diagnosis of respiratory tract infections
|
WO2023104975A1
(en)
|
2021-12-08 |
2023-06-15 |
B.R.A.H.M.S Gmbh |
Biomarkers for prognosis of early onset preeclampsia
|
WO2023110832A1
(en)
|
2021-12-13 |
2023-06-22 |
UNIVERSITé LAVAL |
Biomarkers for the prediction of preterm birth
|
WO2024121392A1
(en)
|
2022-12-08 |
2024-06-13 |
B.R.A.H.M.S Gmbh |
Multiple sflt-1 measurements for prognosis of early onset preeclampsia
|